Charles River 25 févr. 2026 Charles River sells manufacturing and discovery businesses to fulfill promised pivot - Fierce Biotech
Endpoints News 18 févr. 2026 Charles River highlights increase in demand as tariff uncertainties fade
Charles River 9 févr. 2026 Synthace collaborates with Charles River to offer the global pharma industry more robust, faster and cost-effective assays - News-Medical
Charles River 4 févr. 2026 Charles River Laboratories to Close Maryland Cell Therapy Site, Cut 20 Jobs - Contract Pharma
Charles River 3 févr. 2026 Charles River to close cell therapy CDMO site, lay off 20 staffers - Fierce Biotech
FierceBiotech 28 janv. 2026 Reducing animal testing 'an evolution and not a revolution' for life sci R&D, Charles River's incoming CEO says
Charles River 28 janv. 2026 Reducing animal testing 'an evolution and not a revolution' for life sci R&D, Charles River's incoming CEO says - Fierce Biotech
FierceBiotech 8 janv. 2026 Longtime Charles River leader Jim Foster to retire, with COO set to take the helm
Endpoints News 29 déc. 2025 ASK Pharm makes China rights deal; Unicycive resubmits kidney drug after CRL
Endpoints News 24 déc. 2025 Sanofi to buy hepatitis B vaccine maker Dynavax for $2.2B; gets CRL for MS drug
Charles River 14 nov. 2025 Charles River lays off about 70 staffers in relocation as strategic shift begins - Fierce Biotech